Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

Respiratory illnesses like the flu and COVID-19 spread more commonly in the fall and winter months ahead, and doctors in ...

RSV season is upon us, which means thousands of children under five years of age and hundreds of thousands of adults will be ...

Mums and their newborns will now have free access to protection against RSV. ‘We are going to be perfect friends’: Donald ...

In 2025, eligible pregnant women will be able to receive the respiratory syncytial virus (RSV) vaccine for free under the ...

The respiratory virus is the leading cause of hospitalisation for infants, with 12,000 babies admitted each year. Before next ...

Pregnant women and babies will have greater protection against a condition known as respiratory syncytial virus as part of an ...

In three months, the distribution of RSV vaccines will begin in the Americas, according to a PAHO announcement.

Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...

The Royal Australian College of GPs (RACGP) has lauded the Federal Government's announcement of $174.5 million to provide free RSV vaccination during ...

The Australian government has said it will make vaccination against respiratory syncytial virus (RSV) free for newborns and pregnant women starting in 2025. Mark Butler, the minister for health, on ...